Development and characterization of dual drug loaded magnetic gold nanohybrid system for osteoarthritis
Journal of Biomaterials Applications · 2025
DOI: 10.1177/08853282251324352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Gul Rehman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Gold, Osteoarthritis, Chondroitin Sulfates, Glucosamine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Cartilage deterioration in patients with osteoarthritis presents a significant challenge, primarily attributable to the inadequate oral bioavailability and poor dosage compliance of chondroprotective agents. The Chondroitin Sulphate (CS) is a stabilizing and reducing agent for metal NP as well as homing agent by binding to surface molecules (CD44, L-selectin, P-selectin, and annexin-6) of chondrocytes at the OA site. This study was designed to develop intra-articular magnetic gold nanohybrids for the co-delivery of chondroitin sulfate, glucosamine sulfate, and gold, aiming to achieve synergistic anti-inflammatory and cartilage regenerative effects and in vitro assessments of drug release were conducted. Additionally, in animal study, the male albino rats underwent anesthesia by inhaling isoflurane using the open-drop exposure method, and chondrocytes were then harvested for cytotoxicity and biocompatibility assays. Physical characterization revealed 66 nm particle size with uniform distribution and colloidal stability of MGN-CS-GS. Zeta potential and FTIR analysis showed electrostatic interaction between the carboxyl and amino groups of MGN-CS and GS. VSM and EDX confirmed paramagnetic and core-shell characteristics of nanohybrids, respectively. It was found that the MGN-CS-GS released more CS (72%) and GS (85%) at acidic pH with continuous release pattern, which will improve patient compliance. The nanohybrid’s cytotoxicity assay demonstrated excellent biocompatibility and cellular viability of OA chondrocytes triggered by interleukin-1β (IL-1β) compared to marketed formulation. The results demonstrated that MGN-CS-GS continuously released both drugs with high biocompatibility and cellular viability of OA chondrocytes. The successful synthesis of MGN-CS-GS is a foundation for further research on its potential application as a novel co-drug carrier nanohybrid system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
- Department of Pharmacy, IQRA University Chak Shahzad Campus, Islamabad, Pakistan.
- Department of Allied Health Sciences, Sarhad University of Science and Information Technology, Islamabad, Pakistan.
- Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
- Department of Community Dentistry and Behavioral Science, University of Florida, Gainesville, FL, USA.
- College of Agriculture Engineering and Food Science Shandong University of Technology, Zibo, China.
ORCID-Profile: Tawaf Ali Shah
Zitieren
APA
Rehman, G., Khan, J., Alrashed, M. M., Abbas, M., Rehman, M. U., Shah, T. A., Attia, K. A., & Mohammed, A. A. (2025). Development and characterization of dual drug loaded magnetic gold nanohybrid system for osteoarthritis. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251324352
Vancouver
Rehman G, Khan J, Alrashed MM, Abbas M, Rehman MU, Shah TA, et al. Development and characterization of dual drug loaded magnetic gold nanohybrid system for osteoarthritis. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251324352
BibTeX
@article{Rehman2025,
author = {Rehman, Gul and Khan, Jadoon and Alrashed, May M and Abbas, Muhammad and Rehman, Masood Ur and Shah, Tawaf Ali and Attia, Kotb A and Mohammed, Arif Ahmed},
title = {Development and characterization of dual drug loaded magnetic gold nanohybrid system for osteoarthritis},
journal = {Journal of Biomaterials Applications},
year = {2025},
doi = {10.1177/08853282251324352}
}
EUVIMED